A genome-scale CRISPR-Cas9 screening method for protein stability reveals novel regulators of Cdc25A

被引:27
|
作者
Wu, Yuanzhong [1 ]
Zhou, Liwen [1 ]
Wang, Xin [1 ]
Lu, Jinping [2 ,3 ]
Zhang, Ruhua [1 ]
Liang, Xiaoting [1 ]
Wang, Li [1 ]
Deng, Wuguo [1 ]
Zeng, Yi-Xin [1 ]
Huang, Haojie [1 ,4 ]
Kang, Tiebang [1 ,5 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China
[2] Jinan Univ, Zhuhai Hosp, Zhuhai Peoples Hosp, Clin Lab, Zhuhai, Peoples R China
[3] Jinan Univ, Med Res Ctr, Zhuhai, Peoples R China
[4] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA
[5] Guangzhou Doublle Bioprod Co Ltd, Guangdong Prov Key Lab Tumor Targeted Drugs, Guangzhou, Guangdong, Peoples R China
关键词
acetylation; Cdc25A; CRISPR-Cas9; screening; protein stability; ubiquitination; SCF UBIQUITIN LIGASE; BETA-TRCP; DEGRADATION; CELLS; NETWORKS; INSIGHTS;
D O I
10.1038/celldisc.2016.14
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The regulation of stability is particularly crucial for unstable proteins in cells. However, a convenient and unbiased method of identifying regulators of protein stability remains to be developed. Recently, a genome-scale CRISPR-Cas9 library has been established as a genetic tool to mediate loss-of-function screening. Here, we developed a protein stability regulators screening assay (Pro-SRSA) by combining the whole-genome CRISPR-Cas9 library with a dual-fluorescence-based protein stability reporter and high-throughput sequencing to screen for regulators of protein stability. Using Cdc25A as an example, Cul4B-DDB1DCAF8 was identified as a new E3 ligase for Cdc25A. Moreover, the acetylation of Cdc25A at lysine 150, which was acetylated by p300/CBP and deacetylated by HDAC3, prevented the ubiquitin-mediated degradation of Cdc25A by the proteasome. This is the first study to report that acetylation, as a novel posttranslational modification, modulates Cdc25A stability, and we suggest that this unbiased CRISPR-Cas9 screening method at the genome scale may be widely used to globally identify regulators of protein stability.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Genome-scale CRISPR-Cas9 screening to identify essential genes and pathways in pancreatic cancer
    Aguirre, Andrew J.
    Shao, Wei
    Xu, Han
    Weir, Barbara
    Vazquez, Francisca
    Meyers, Robin
    Zhang, Cheng-Zhong
    Doshi, Mihir
    Cowley, Glenn S.
    Ewachiw, Theodore
    Rasheed, Zeshaan
    Golub, Todd R.
    Stegmaier, Kimberly
    Roberts, Charles W.
    Garraway, Levi A.
    Meyerson, Matthew
    Tsherniak, Aviad
    Root, David E.
    Espenshade, Peter J.
    Hahn, William C.
    CANCER RESEARCH, 2016, 76
  • [22] Genome-Scale CRISPR-Cas9 Knockout Screening in Nasopharyngeal Carcinoma for Radiosensitive and Radioresistant Genes
    Ziyan, Z.
    Shen, M.
    Jixi, L.
    Kang, L.
    Shi, S.
    Chen, W.
    Chen, S.
    Yin, Y.
    Qin, Y.
    Kang, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E389 - E389
  • [23] Identification of Novel Regulators of Erythropoiesis Using Whole-Genome CRISPR-Cas9 Screening
    Myers, Greggory
    Yu, Lei
    Balbin-Cuesta, Ginette
    Ozel, Ayse Bilge
    Engel, James Douglas
    Khoriaty, Rami
    BLOOD, 2022, 140 : 8155 - 8156
  • [24] Genome-scale CRISPR-Cas9 screening stratifies pancreatic cancer with distinct outcomes and immunotherapeutic efficacy
    Wang, Libo
    Fu, Deshuang
    Weng, Siyuan
    Xu, Hui
    Liu, Long
    Guo, Chunguang
    Ren, Yuqing
    Liu, Zaoqu
    Han, Xinwei
    CELLULAR SIGNALLING, 2023, 110
  • [25] Guide Swap enables genome-scale pooled CRISPR-Cas9 screening in human primary cells
    Ting, Pamela Y.
    Parker, Albert E.
    Lee, J. Scott
    Trussell, Chris
    Sharif, Orzala
    Luna, Fabio
    Federe, Glenn
    Barnes, S. Whitney
    Walker, John R.
    Vance, Julie
    Gao, Mu-Yun
    Klock, Heath E.
    Clarkson, Scott
    Russ, Carsten
    Miraglia, Loren J.
    Cooke, Michael P.
    Boitano, Anthony E.
    McNamara, Peter
    Lamb, John
    Schmedt, Christian
    Snead, Jennifer L.
    NATURE METHODS, 2018, 15 (11) : 941 - +
  • [26] Use of CRISPR-cas9 gene targeting for genome-scale CRISPR screening in a glioma stem-cell line
    Noorani, Imran
    Bradley, Allan
    LANCET, 2016, 387 : 78 - 78
  • [27] Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening (vol 12, pg 828, 2017)
    Joung, Julia
    Konermann, Silvana
    Gootenberg, Jonathan S.
    Abudayyeh, Omar O.
    Platt, Randall J.
    Brigham, Mark D.
    Sanjana, Neville E.
    Zhang, Feng
    NATURE PROTOCOLS, 2019, 14 (07) : 2259 - 2259
  • [28] Screening Genes Promoting Exit from Naive Pluripotency Based on Genome-Scale CRISPR-Cas9 Knockout
    Yang, Bin
    Kuang, Junqi
    Wu, Chuman
    Zhou, Wenyi
    Zhu, Shuoji
    Jiang, Haodong
    Zhai, Ziwei
    Wu, Yue
    Peng, Junwei
    Liu, Nanbo
    Hu, Haiyan
    Ide, Nasser Moussa
    Chen, Ruiping
    Zhao, Mingyi
    Zhu, Ping
    STEM CELLS INTERNATIONAL, 2020, 2020
  • [29] Genome-Scale CRISPR-Cas9 Transcriptional Activation Screening in Metformin Resistance Related Gene of Prostate Cancer
    Chen, Jiahong
    Huang, Yaqiang
    Tang, Zhenfeng
    Li, Maozhang
    Ling, Xiaohui
    Liao, Jinxian
    Zhou, Xiaobo
    Fang, Shumin
    Zhao, Haibo
    Zhong, Weide
    Yuan, Xia
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 8
  • [30] Development of capability for genome-scale CRISPR-Cas9 knockout screens in New Zealand
    Hunter, Francis W.
    Tsai, Peter
    Kakadia, Purvi M.
    Bohlander, Stefan K.
    Print, Cristin G.
    Wilson, William R.
    JOURNAL OF THE ROYAL SOCIETY OF NEW ZEALAND, 2018, 48 (04) : 245 - 261